Drug Type Small molecule drug |
Synonyms BAY 1082439, BAY1082439 |
Target |
Action inhibitors |
Mechanism PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors), PI3Kβ inhibitors(Phosphatidylinositol 3 kinase beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H30N6O5 |
InChIKeyJGNRMIWLBBNSMU-QGZVFWFLSA-N |
CAS Registry1375469-38-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | United States | 21 Nov 2012 | |
Advanced cancer | Phase 1 | Singapore | 21 Nov 2012 | |
Advanced cancer | Phase 1 | Taiwan Province | 21 Nov 2012 | |
Neoplasms | IND Application | China | 28 Mar 2013 | |
Neoplasms | IND Application | China | 28 Mar 2013 |